Lumbar Disc Herniation
2
Pipeline Programs
1
Companies
7
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Intrinsic TherapeuticsMA - Woburn
7 programs2
6mm annular closure devicePhase 41 trial
BarricaidPhase 41 trial
Annular closureN/A1 trial
Annular closure deviceN/A1 trial
BarricaidN/A1 trial
+2 more programsActive Trials
+4 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Intrinsic Therapeutics6mm annular closure device
Intrinsic TherapeuticsBarricaid
Intrinsic TherapeuticsAnnular closure
Intrinsic TherapeuticsIncidence of Large Annular Defects in Primary Lumbar Discectomy Patients
Intrinsic TherapeuticsAnnular closure device
Intrinsic TherapeuticsFollow up per standard of care
Intrinsic TherapeuticsBarricaid
Clinical Trials (7)
Total enrollment: 1,014 patients across 7 trials
A Post Marketing Surveillance Study
Start: Jan 2018Est. completion: Dec 202420 patients
Phase 4Active Not Recruiting
A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation
Start: Dec 2010Est. completion: Jun 2025554 patients
Phase 4Unknown
PMCFU of an Annular Closure System
Start: Sep 2023Est. completion: Oct 2025250 patients
N/AUnknown
NCT03252691Intrinsic TherapeuticsIncidence of Large Annular Defects in Primary Lumbar Discectomy Patients
Incidence of Large Annular Defects in Primary Lumbar Discectomy Patients
Start: Sep 2020Est. completion: May 20210
N/AWithdrawn
Study of Lumbar Discectomy With Annular Closure
Start: May 2020Est. completion: Dec 202455 patients
N/AUnknown
Post-Marketing Clinical Follow-Up of a Spine Implant
Start: Mar 2017Est. completion: Sep 202490 patients
N/AUnknown
Barricaid EU Post Market Study for Primary Lumbar Disc Herniation
Start: Apr 2009Est. completion: Mar 201345 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space